Four gene markers, BARD1 (BRCA-associated RING domain 1), SOD2 (superoxide dismutase 2), S100A10, and TSC22D3 (TSC22 domain family member 3), were found to be the targets of several approved cancer drugs. The gene discussed is SOD2; the disease is cancer.